Pain management after tonsillectomy-by demand or by-the-clock-is there a difference?

QUIPS patient reported outcome measure postoperative pain quality management

Journal

Ear, nose, & throat journal
ISSN: 1942-7522
Titre abrégé: Ear Nose Throat J
Pays: United States
ID NLM: 7701817

Informations de publication

Date de publication:
21 Jul 2022
Historique:
entrez: 21 7 2022
pubmed: 22 7 2022
medline: 22 7 2022
Statut: aheadofprint

Résumé

To improve pain management after tonsillectomy (TE) by comparing individual analgesic management by demand versus a fixed-scheduled analgesic treatment protocol in a prospective trial. Forty consecutive patients received individual pain treatment by demand (control group) followed by 40 patients who were treated by a fixed-scheduled four-staged escalating analgesic protocol (intervention group) after TE. Minimum and maximum pain as well as pain on ambulation (NRS 0-10) on the first postoperative day were defined as primary objectives. Secondary endpoints comprised the analgesic score, treatment-related side effects/pain-associated impairments, wish for more pain medication, and patient satisfaction. Patients were surveyed using the standardized and validated "Quality Improvement in Postoperative Pain Treatment" (QUIPS) questionnaire. Patients of the control group reported comparable minimum (2.03 ± 1.42 vs 2.38 ± 1.79, Pain control following TE was not distinctly affected by applying a fixed-scheduled analgesic treatment protocol compared to individual analgesic therapy. In conclusion, analgesic treatment after TE remains unsatisfying. Consequently, further efforts are needed to achieve a standardized and effective approach to the underlying pathophysiological causes of pain following TE.

Identifiants

pubmed: 35861363
doi: 10.1177/01455613221116223
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1455613221116223

Auteurs

Magdalena Gostian (M)

Department of Anesthesiology and Intensive Care Medicine, 232691Malteser Waldkrankenhaus St. Marien, Erlangen, Germany.

Lisa Stilkerich (L)

Department of Otolaryngology, Head & Neck Surgery, 59991Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Anne Pauly (A)

Clinic Pharmacy, 9171Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.

Frank Waldfahrer (F)

Department of Otolaryngology, Head & Neck Surgery, 59991Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Matthias Balk (M)

Department of Otolaryngology, Head & Neck Surgery, 59991Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Robin Rupp (R)

Department of Otolaryngology, Head & Neck Surgery, 59991Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Moritz Allner (M)

Department of Otolaryngology, Head & Neck Surgery, 59991Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Heinrich Iro (H)

Department of Otolaryngology, Head & Neck Surgery, 59991Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Antoniu-Oreste Gostian (AO)

Department of Otolaryngology, Head & Neck Surgery, 59991Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Classifications MeSH